DUBLIN–(BUSINESS WIRE)–The “Peptide Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Peptide Therapeutics Market to Reach $47 Billion by 2027
Amid the COVID-19 crisis, the global market for Peptide Therapeutics estimated at US$27.2 Billion in the year 2020, is projected to reach a revised size of US$47 Billion by 2027, growing at a CAGR of 8.1% over the period 2020-2027.
Innovative, one of the segments analyzed in the report, is projected to record 6.6% CAGR and reach US$28 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Generic segment is readjusted to a revised 10.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $7.4 Billion, While China is Forecast to Grow at 12.3% CAGR
The Peptide Therapeutics market in the U.S. is estimated at US$7.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.5 Billion by the year 2027 trailing a CAGR of 12.1% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 46 Featured):
AbbVie, Inc.
Advanced Accelerator Applications SA
Akashi Therapeutics, Inc.
Amgen, Inc.
Anthera Pharmaceuticals, Inc.
AstraZeneca PLC
Bachem AG
Bristol-Myers Squibb Company
Cardiorentis AG
Corden Pharma International GmbH
Debiopharm Group
Derma Sciences, Inc.
Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline PLC
Hanmi Pharmaceutical Co., Ltd.
Insmed, Inc.
Ipsen Group
Johnson & Johnson
Lonza Group AG
Mallinckrodt PLC
Merck & Co., Inc.
MolMed S.p.A.
Novartis AG
Novo Nordisk A/S
Nymox Pharmaceutical Corporation
PAR Pharmaceutical Companies, Inc.
PeptiDream Inc.
Pfizer, Inc.
PolyPeptide Group
Radius Health, Inc.
Repligen Corporation
Sanofi SA
SciClone Pharmaceuticals Holding Limited.
Shire PLC
Takeda Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
The Medicines Company
X-GEN Pharmaceuticals, Inc.
Zealand Pharma A/S
Zydus Cadila
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
IV. COMPETITION
Total Companies Profiled: 46
For more information about this report visit https://www.researchandmarkets.com/r/x0hlr0
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900